CIK 0000730272 · Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 042729386
- Phone
- 7814499560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-13 | Bylund James Chief Operating Officer | Shares withheld for taxes | −175 | $142.44 | $25K | 24,165 |
| 2025-03-03 | Garland Jason K CFO | Grant or award | +6,435 | 13,795 | ||
| 2025-03-03 | Garland Jason K CFO | Grant or award · Stock Option (Right to Buy) | +6,056 | 6,056 | ||
| 2025-03-03 | KURIYEL RALF Senior VP, R&D | Grant or award | +4,826 | 16,448 | ||
| 2025-03-03 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −386 | $155.38 | $60K | 16,062 |
| 2025-03-03 | KURIYEL RALF Senior VP, R&D | Grant or award · Stock Option (Right to Buy) | +4,542 | 4,542 | ||
| 2025-03-03 | Hunt Anthony Director | Shares withheld for taxes | −10,142 | $155.38 | $1.6M | 136,301 |
| 2025-03-03 | Bylund James Chief Operating Officer | Grant or award | +6,435 | 25,198 | ||
| 2025-03-03 | Bylund James Chief Operating Officer | Shares withheld for taxes | −1,239 | $155.38 | $193K | 23,959 |
| 2025-03-03 | Bylund James Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +6,056 | 6,056 | ||
| 2025-03-03 | Loeillot Olivier Chief Executive Officer | Grant or award | +14,480 | 46,693 | ||
| 2025-03-03 | Loeillot Olivier Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +13,627 | 13,627 | ||
| 2025-02-27 | Garland Jason K CFO | Shares withheld for taxes | −316 | $156.54 | $49K | 7,360 |
| 2025-02-27 | Loeillot Olivier Chief Executive Officer | Shares withheld for taxes | −343 | $156.54 | $54K | 32,213 |
| 2025-02-27 | Bylund James Chief Operating Officer | Shares withheld for taxes | −1,285 | $156.54 | $201K | 18,763 |
| 2025-02-27 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −391 | $156.54 | $61K | 11,622 |
| 2025-02-27 | Hunt Anthony Director | Shares withheld for taxes | −2,825 | $156.54 | $442K | 146,443 |
| 2025-02-24 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −275 | $164.74 | $45K | 12,013 |
| 2025-02-24 | Bylund James Chief Operating Officer | Shares withheld for taxes | −543 | $164.74 | $89K | 20,048 |
| 2025-02-24 | Hunt Anthony Director | Shares withheld for taxes | −2,380 | $164.74 | $392K | 149,268 |
Page 8 of 11 · 215 trades